Unraveling the interactions between environmental factors and genetic polymorphisms in non-Hodgkin lymphoma risk

References

• Last JM. A Dictionary of Epidemiology. Oxford University Press, Oxford, UK (2001).
   Google Scholar
• Garcia-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet366(9486), 649–659 (2005).
   PubMed Web of Science ®Google Scholar
• Chatterjee N, Kalaylioglu Z, Moslehi R, Peters U, Wacholder S. Powerful multilocus tests of genetic association in the presence of gene–gene and gene–environment interactions. Am. J. Hum. Genet.79(6), 1002–1016 (2006).
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Ahn J, Gruber SB, Rennert G, Moreno V, Chatterjee N. Tests for gene–environment interaction from case–control data: a novel study of type I error, power and designs. Genet. Epidemiol.32(7), 615–626 (2008).
   PubMedGoogle Scholar
• Mukherjee B, Chatterjee N. Exploiting gene–environment independence for analysis of case–control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics64(3), 685–694 (2008).
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood107(1), 265–276 (2006).
   PubMed Web of Science ®Google Scholar
• Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann. Hematol.84(1), 1–12 (2005).
   PubMed Web of Science ®Google Scholar
• Khoury MJ, Wacholder S. Invited commentary: from genome-wide association studies to gene–environment-wide interaction studies – challenges and opportunities. Am. J. Epidemiol.169(2), 227–230 (2009).
   PubMedGoogle Scholar
• Morton LM, Wang SS, Cozen W et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood112(13), 5150–5160 (2008).
   PubMed Web of Science ®Google Scholar
• Alpen B, Robbecke J, Wundisch T, Stolte M, Neubauer A. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin’s lymphoma (NHL). Ann Hematol.80(Suppl. 3), B106–B107 (2001).
   Google Scholar
• Tursi A, Brandimarte G, Torello M. Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy. J. Clin. Gastroenterol.38(4), 360–363 (2004).
   PubMed Web of Science ®Google Scholar
• Dohden K, Kaizaki Y, Hosokawa O, Hayashi H, Hattori M. Regression of rectal mucosa-associated lymphoid tissue lymphoma but persistence of Helicobacter pylori infection of gastric mucosa after administration of levofloxacin: report of a case. Dis. Colon Rectum47(9), 1544–1546 (2004).
   PubMedGoogle Scholar
• Landgren O, Albitar M, Ma W et al. B-cell clones as early markers for chronic lymphocytic leukemia. N. Engl. J. Med.360(7), 659–667 (2009).
   PubMed Web of Science ®Google Scholar
• Marti G, Abbasi F, Raveche E et al. Overview of monoclonal B-cell lymphocytosis. Br. J. Haematol.139(5), 701–708 (2007).
   PubMed Web of Science ®Google Scholar
• Morton LM, Turner JJ, Cerhan JR et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood110(2), 695–708 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leuk. Lymphoma44(Suppl. 3), S41–S47 (2003).
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin. Oncol.29(3), 258–263 (2002).
   PubMed Web of Science ®Google Scholar
• Baecklund E, Backlin C, Iliadou A et al. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum.54(12), 3774–3781 (2006).
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood103(1), 275–282 (2004).
   PubMed Web of Science ®Google Scholar
• Choi WW, Weisenburger DD, Greiner TC et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin. Cancer Res.15(17), 5494–5502 (2009).
   PubMed Web of Science ®Google Scholar
• Pike BL, Greiner TC, Wang X et al. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia22(5), 1035–1043 (2008).
   PubMed Web of Science ®Google Scholar
• Chiu BC, Lan Q, Dave BJ, Blair A, Zahm SH, Weisenburger DD. The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J. Natl Cancer Inst. Monogr.(39), 69–73 (2008).
   PubMedGoogle Scholar
• Chiu BC, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood108(4), 1363–1369 (2006).
   PubMed Web of Science ®Google Scholar
• Hartge P, Wang S, Bracci PM, Devesa SS, Holly EA. Non Hodgkin lymphoma. In: Cancer Epidemiology and Prevention.Schottenfeld D, Fraumeni J Jr (Eds). Oxford University Press, Oxford, UK (2009).
   Google Scholar
• Ekstrom SK, Vajdic CM, Falster M et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood111(8), 4029–4038 (2008).
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Falster MO, de SS et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res.69(16), 6482–6489 (2009).
   PubMed Web of Science ®Google Scholar
• Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev.16(3), 405–408 (2007).
   PubMed Web of Science ®Google Scholar
• Melbye M, Smedby KE, Lehtinen T et al. Atopy and risk of non-Hodgkin lymphoma. J. Natl. Cancer Inst.99(2), 158–166 (2007).
   PubMedGoogle Scholar
• Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J. Intern. Med.264(6), 537–548 (2008).
   PubMed Web of Science ®Google Scholar
• de SS, Benavente Y, Vajdic CM et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin. Gastroenterol. Hepatol.6(4), 451–458 (2008).
   PubMedGoogle Scholar
• Wang SS, Hartge P. Etiology and epidemiology of non-Hodgkin lymphoma. In: Non-Hodgkin Lymphoma.Mauch PM, Armitage JO, Harris NL, Coiffier B, Dalla-Favera R (Eds). Lippincott, Williams and Wilkins, PA, USA (2010).
   Google Scholar
• Hoffman AE, Zheng T, Stevens RG et al. Clock–cancer connection in non-Hodgkin’s lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res.69(8), 3605–3613 (2009).
   PubMed Web of Science ®Google Scholar
• Purdue MP, Severson RK, Colt JS et al. Degreasing and risk of non-Hodgkin lymphoma. Occup. Environ. Med.66(8), 557–560 (2009).
   PubMedGoogle Scholar
• Wang R, Zhang Y, Lan Q et al. Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am. J. Epidemiol.169(2), 176–185 (2009).
   PubMed Web of Science ®Google Scholar
• Kricker A, Armstrong BK, Hughes AM et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int. J. Cancer122(1), 144–154 (2008).
   PubMed Web of Science ®Google Scholar
• Morton LM, Zheng T, Holford TR et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol.6(7), 469–476 (2005).
   PubMed Web of Science ®Google Scholar
• Lu Y, Prescott J, Sullivan-Halley J et al. Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am. J. Epidemiol.170(10), 1231–1240 (2009).
   PubMed Web of Science ®Google Scholar
• Kelemen LE, Wang SS, Lim U et al. Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk. Cancer Causes Control19(5), 491–503 (2008).
   PubMedGoogle Scholar
• Willett EV, Morton LM, Hartge P et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int. J. Cancer122(9), 2062–2070 (2008).
   PubMed Web of Science ®Google Scholar
• Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N. Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case–control analysis. Cancer Epidemiol. Biomarkers Prev.13(10), 1665–1676 (2004).
   PubMed Web of Science ®Google Scholar
• Morton LM, Hartge P, Holford TR et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol. Biomarkers Prev.14(4), 925–933 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sanjose SD, Bracci PM et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am. J. Epidemiol.167(11), 1321–1331 (2008).
   PubMed Web of Science ®Google Scholar
• Karlson EW, Chibnik LB, Tworoger SS et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum.60(3), 641–652 (2009).
   PubMedGoogle Scholar
• Grulich AE, Wan X, Law MG et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin’s lymphoma in people with AIDS. AIDS14(2), 133–140 (2000).
   PubMed Web of Science ®Google Scholar
• Engels EA, Chatterjee N, Cerhan JR et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI–SEER multi-center case–control study. Int. J. Cancer111(1), 76–80 (2004).
   PubMed Web of Science ®Google Scholar
• Waterland RA. Is epigenetics an important link between early life events and adult disease? Horm. Res.71(Suppl. 1), 13–16 (2009).
   PubMedGoogle Scholar
• Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med.359(1), 61–73 (2008).
   PubMed Web of Science ®Google Scholar
• Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica92(7), 960–969 (2007).
   PubMed Web of Science ®Google Scholar
• Wang SS, Cerhan JR, Hartge P et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res.66(19), 9771–9780 (2006).
   PubMed Web of Science ®Google Scholar
• Rothman N, Skibola CF, Wang SS et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol.7(1), 27–38 (2006).
   PubMed Web of Science ®Google Scholar
• Skibola CF, Bracci PM, Halperin E et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat. Genet.41(8), 873–875 (2009).
   PubMed Web of Science ®Google Scholar
• Di Bernardo MC, Crowther-Swanepoel D, Broderick P et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet.40(10), 1204–1210 (2008).
   PubMed Web of Science ®Google Scholar
• Wang SS, Cozen W, Cerhan JR et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res.67(10), 5042–5054 (2007).
   PubMed Web of Science ®Google Scholar
• Colt JS, Rothman N, Severson RK et al. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood113(9), 1899–1905 (2009).
   PubMed Web of Science ®Google Scholar
• Han J, Kraft P, Nan H et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet.4(5), e1000074 (2008).
   PubMed Web of Science ®Google Scholar
• Wang SS, Purdue MP, Cerhan JR et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS ONE4(4), e5360 (2009).
   PubMed Web of Science ®Google Scholar
• Gathany AH, Hartge P, Davis S et al. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control20(8), 1291–1302 (2009).
   PubMedGoogle Scholar
• Morton LM, Schenk M, Hein DW et al. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Pharmacogenet. Genomics16(8), 537–545 (2006).
   PubMed Web of Science ®Google Scholar
• Lim U, Wang SS, Hartge P et al. Gene–nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case–control study. Blood109(7), 3050–3059 (2007).
   PubMed Web of Science ®Google Scholar
• Purdue MP, Hartge P, Davis S et al. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control18(9), 989–999 (2007).
   PubMed Web of Science ®Google Scholar
• Morton LM, Bernstein L, Wang SS et al. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis28(8), 1759–1764 (2007).
   PubMed Web of Science ®Google Scholar
• Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis24(2), 117–125 (2009).
   PubMed Web of Science ®Google Scholar
• Besson C, Amiel C, Le-Pendeven C et al. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein–Barr virus-related lymphomas. J. Infect. Dis.199(8), 1121–1127 (2009).
   PubMedGoogle Scholar
• Gao L, Weck MN, Michel A, Pawlita M, Brenner H. Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res.69(7), 2973–2980 (2009).
   PubMedGoogle Scholar
• Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res.69(15), 6164–6170 (2009).
   PubMedGoogle Scholar
• Hoeft B, Becker N, Deeg E, Beckmann L, Nieters A. Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes Control19(2), 163–173 (2008).
   PubMed Web of Science ®Google Scholar
• Willett EV, Skibola CF, Adamson P et al. Non-Hodgkin’s lymphoma, obesity and energy homeostasis polymorphisms. Br. J. Cancer93(7), 811–816 (2005).
   PubMed Web of Science ®Google Scholar
• Skibola CF, Holly EA, Forrest MS et al. Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev.13(5), 779–786 (2004).
   PubMed Web of Science ®Google Scholar
• Han X, Zheng T, Lan Q et al. Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev.18(5), 1429–1438 (2009).
   PubMedGoogle Scholar
• Kilfoy BA, Zheng T, Lan Q et al. Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Am. J. Hematol.84(5), 279–282 (2009).
   PubMedGoogle Scholar